Ardeparin
Clinical data
AHFS/Drugs.comMultum Consumer Information
Routes of
administration		Injection
ATC code
  • None
Legal status
Legal status
Pharmacokinetic data
Bioavailability92%
Identifiers
  • 6-[5-acetylamino-4,6-dihydroxy-2-(sulfooxymethyl)tetrahydropyran-3-yl]oxy-3-[5-(6-
CAS Number
DrugBank
ChemSpider
  • none
UNII
ChEMBL
CompTox Dashboard (EPA)
ECHA InfoCard100.110.590 Edit this at Wikidata
Chemical and physical data
Formula(C26H40N2O36S5)n
Molar mass5500–6500 g/mol (average)
 ☒NcheckY (what is this?)  (verify)

Ardeparin (brand name Normiflo) is an anticoagulant. It was used for the prevention of deep vein thrombosis, but was withdrawn from the US market in 2000 for reasons unrelated to safety or efficacy.[1][2][3]

References

  1. ^ Frishman WH, Cheng-Lai A, Chen J (2000). "Antithrombotic therapy". Current cardiovascular drugs (3rd ed.). Philadelphia, Pa.: Current Medicine. p. 90. ISBN 978-1-4615-6767-7.
  2. ^ "Normiflo". Drugs.com. Archived from the original on 19 February 2017. Retrieved 23 January 2018.
  3. ^ "Determination That Ardeparin Sodium Injection Was Not Withdrawn From Sale for Reasons of Safety or Effectiveness". United States Food and Drug Administration. Federal Register. Retrieved 24 June 2022.


Categories